Growth Differentiation Factor-15 Levels at Admission Provide Incremental Prognostic Information on All-Cause Long-term Mortality in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention.
GDF-15
Mortality
NTproBNP
Prognosis
Risk stratification
STEMI
Journal
Cardiology and therapy
ISSN: 2193-8261
Titre abrégé: Cardiol Ther
Pays: England
ID NLM: 101634495
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
02
12
2018
pubmed:
1
2
2019
medline:
1
2
2019
entrez:
1
2
2019
Statut:
ppublish
Résumé
To investigate the additive prognostic value of growth differentiation factor (GDF-15) levels in ST-segment elevation myocardial infarction (STEMI) patients treated with primary percutaneously coronary intervention (pPCI) with 10-year mortality on top of clinical characteristics and known cardiac biomarkers. Baseline serum GDF-15 levels were measured in 290 STEMI patients treated with pPCI in the MISSION! intervention trial conducted from February 1, 2004 through October 31, 2006. The incremental prognostic value of GDF-15 and NTproBNP levels was evaluated on top of clinical characteristics using Cox proportional hazards analysis, Chi-square models and C-index. Outcome was 10-year all-cause mortality. Mean age was 59.0 ± 11.5 years and 65 (22.4) patients were female. A total of 37 patients died during a follow-up of 9.4 (IQR 8.8-10.0) years. Multivariable Cox regression revealed GDF-15 and NTproBNP levels above median to be independently associated with 10-year all-cause mortality [HR GDF-15, 2.453 (95% CI 1.064-5.658), P = 0.04; HR NTproBNP, 2.413 (95% CI 1.043-5.564), P = 0.04] after correction for other clinical variables. Stratified by median GDF-15 (37.78 pmol/L) and NTproBNP (11.74 pmol/L) levels, Kaplan-Meier curves showed significant better survival for patients with GDF-15 and NTproBNP levels below the median versus above the median. The likelihood ratio test showed a significant incremental value of GDF-15 (P = 0.03) as compared with a model with clinically important variables and NTproBNP. The C-statistics for this model improved from 0.82 to 0.84 when adding GDF-15. GDF-15 levels at admission in STEMI patients are independently associated with 10-year all-cause mortality rates and could improve risk stratification on top of clinical variables and other cardiac biomarkers.
Identifiants
pubmed: 30701401
doi: 10.1007/s40119-019-0127-4
pii: 10.1007/s40119-019-0127-4
pmc: PMC6525222
doi:
Types de publication
Journal Article
Langues
eng
Pagination
29-41Références
Circulation. 2000 Oct 24;102(17):2031-7
pubmed: 11044416
Eur Heart J. 2003 Jan;24(1):28-66
pubmed: 12559937
Circulation. 2004 Aug 31;110(9):e82-292
pubmed: 15339869
Heart. 2006 Jun;92(6):735-40
pubmed: 16251228
Circ Res. 2006 Feb 17;98(3):351-60
pubmed: 16397141
Circ Res. 2006 Feb 17;98(3):342-50
pubmed: 16397142
Eur Heart J. 2006 Feb;27(4):419-26
pubmed: 16407373
Am Heart J. 2007 Jan;153(1):14.e1-11
pubmed: 17174628
Clin Chem. 2007 Feb;53(2):284-91
pubmed: 17185363
Circulation. 2007 Feb 27;115(8):962-71
pubmed: 17283261
J Am Coll Cardiol. 2008 Feb 12;51(6):618-26
pubmed: 18261680
Eur Heart J. 2009 May;30(9):1057-65
pubmed: 19168526
Eur Heart J. 2009 Oct;30(19):2346-53
pubmed: 19561023
Circ Cardiovasc Genet. 2010 Feb;3(1):88-96
pubmed: 20160200
Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):203-10
pubmed: 20966402
Heart. 2011 Apr;97(8):632-40
pubmed: 21345844
Circulation. 2011 May 17;123(19):2101-10
pubmed: 21536998
Scand J Clin Lab Invest. 2012 Feb;72(1):45-51
pubmed: 22023041
JAMA. 2012 Sep 12;308(10):998-1006
pubmed: 22928184
Curr Heart Fail Rep. 2012 Dec;9(4):337-45
pubmed: 22961192
J Am Coll Cardiol. 2013 Mar 26;61(12):1222-30
pubmed: 23500325
Heart. 2014 Apr;100(7):582-9
pubmed: 24436220
J Am Coll Cardiol. 2014 Nov 18-25;64(20):2101-8
pubmed: 25457398
Am Heart J. 2015 Jun;169(6):879-889.e7
pubmed: 26027627
Eur Heart J. 2016 Apr 21;37(16):1325-33
pubmed: 26417057
Eur J Heart Fail. 2016 Jan;18(1):81-8
pubmed: 26497848
BMC Cardiovasc Disord. 2016 May 06;16:82
pubmed: 27154403
J Am Heart Assoc. 2016 May 20;5(5):
pubmed: 27207959
Clin Chim Acta. 2016 Sep 1;460:211-9
pubmed: 27374304
Ann Transl Med. 2016 Jul;4(13):258
pubmed: 27500159
Clin Chem. 2017 Feb;63(2):573-584
pubmed: 27932413
Curr Cardiol Rep. 2017 Apr;19(4):29
pubmed: 28315120
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Stat Med. 1996 Feb 28;15(4):361-87
pubmed: 8668867
Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11514-9
pubmed: 9326641